Industry and Regulatory Considerations for Healthcare Company Boards

In this episode of S&C’s Critical Insights podcast, Frank Aquila, Global Head of M&A, and Melissa Sawyer, co-head of our Corporate Governance & Activism practice, examine industry and regulatory trends that will shape boardroom discussions at healthcare companies. Frank and Melissa discuss how regulatory activity in other sectors might inform the healthcare industry’s interactions with regulators. They also explore what boards should be thinking about as companies prepare to announce large healthcare acquisitions.

 

For more information, visit us at Sullcrom.com.